Was Part D a Giveaway to the Pharmaceutical Industry?

, &
Inquiry: The Journal of Health Care Organization, Provision, and Financing 44 (1):15-25 (2007)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.5034/inquiryjrnl_44.1.15

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,349

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Understanding physician-pharmaceutical industry interactions.Shaili Jain - 2007 - New York: Cambridge University Press.
Medicine and pharmacy — facts and myths about the development of an innovative pharmaceutical industry in Poland.Włodzimierz Kubiak - 2005 - Science and Engineering Ethics 11 (1):41-51.
The connection between academia and industry.Ajai Singh & Shakuntala Singh - 2005 - Mens Sana Monographs 3 (1):5.
Dangerous Medicine: The Pharmaceutical Industry's Questionable Ethical Practices.John T. Fielding - unknown
How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism.Wendy Lipworth, Kathleen Montgomery & Miles Little - 2013 - Journal of Bioethical Inquiry 10 (3):355-367.
The ethics of the pharmaceutical industry and the need for a dual market system.Anna Kreiner - 1995 - Journal of Medical Humanities 16 (1):55-68.
Big pharma: a story of success in a market economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.
Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society.James M. Huebner - 2014 - Journal of Buisness Ethics (3):1-10.
Where Strategy and Ethics Converge: Pharmaceutical Industry Pricing Policy for Medicare Part D Beneficiaries.Edward R. Balotsky - 2009 - Journal of Business Ethics 84 (S1):75 - 88.
Intellectual Property and Pharmaceutical Drugs.Richard T. De George - 2005 - Business Ethics Quarterly 15 (4):549-575.
.John T. Fielding - unknown
Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda.Paul D. Jorgensen - 2013 - Journal of Law, Medicine and Ethics 41 (3):561-570.
Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility. [REVIEW]Matthew Lee & Jillian Kohler - 2010 - Journal of Business Ethics 95 (4):641-658.

Analytics

Added to PP
2013-12-30

Downloads
16 (#880,136)

6 months
5 (#652,053)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references